MHRA is examining whether those affected have a genetic trait that is leaving them at a greater risk of side effects from the ...

NICE says that in some exceptional circumstances the BMI requirements can drop down to 30, and people from some ethnic minority groups may be eligible at lower levels. If you get through this process, ...

Amanda Bynes Ozempic weight loss journey is making headlines as the former Nickelodeon star revealed plans to lose over 40 ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

Investing.com -- Novo Nordisk A/S (NYSE: NVO) stock dropped 2.1% premarket following news that Spain’s health ministry has requested clarification about the company’s obesity awareness campaign, which ...

Investing.com -- L’action de Novo Nordisk A/S (NYSE: NVO) a chuté de 2,1% en préouverture suite à l’annonce que le ministère de la santé espagnol a demandé des éclaircissements concernant la campagne ...

Diabetes drug Ozempic and weight-loss jab Wegovy may also reduce the risk of dementia, according to a new study. American researchers found that semaglutide - the active ingredient in Ozempic and ...

Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other ...

Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.

Experts have issued GPs with crucial guidance on weight loss jabs to avoid deadly complications, as the injections are ...